HYTN Innovations Inc. formulates, manufactures, markets, and sells premium products that contain psychoactive and psychotropic compounds. The company’s mission is to become the top provider of these products in all federally regulated markets. To achieve this, the company focuses on identifying market opportunities in order to quickly bring its innovative products to market through its elevated development platform.

IMCC is an international medical cannabis company, and a well-known Israeli brand of medical cannabis products. In Europe, IMCC is establishing a fully operational, vertically integrated medical cannabis business spearheaded by its distribution arm in Germany and augmented by strategic agreements with certified EU-GMP Standard suppliers, making it one of the only medical cannabis companies with fully integrated operations in Europe. IMCC intends to leverage IMCC's brand to establish a foothold in emerging medical cannabis markets including Germany, Portugal and Greece.

IONIC BRANDS Corp. is dedicated to building a regionally based multi-state consumer-focused cannabis concentrate brand portfolio with strong roots in the premium and luxury segments of vape concentrates and edibles. The cornerstone brand of the portfolio, IONIC, is a top vaporizer brand in Washington State along with its economy brand Dabulous and has aggressively expanded throughout the Pacific Northwest of the United States. The brand is currently operating in Washington and Oregon. IONIC BRANDS' strategy is to be the leader of the highest-value segments of the cannabis market.

Irwin Naturals is a nutraceutical company that distributes dietary supplements to more than 100,000 retailers, including mass-market retailers.

Investor Note: In addition to the 3,369,368 Subordinate Voting Shares that are listed and trading, there are (i) 340,300 subordinate voting shares reserved for issuance pursuant to the conversion rights attached to the Proportionate Voting Shares of Irwin Naturals Inc. (ii) 18,240 subordinate voting shares reserved for issuance pursuant to the conversion rights attached to the Multiple Voting Shares of Irwin Naturals Inc.; (iii) 320,000,000 subordinate voting shares reserved for issuance pursuant to the exchange rights attached to the Class B Non-Voting Shares of Irwin Naturals, an indirect, wholly-owned subsidiary of Irwin Naturals Inc.; and (iv) 20,000 subordinate voting share purchase warrants.  The total number of equity shares assuming all are converted or exchanged, as applicable, into the listed class would be 323,747,908.